Rectal Cancer Clinical Trial
Official title:
Side-to-end Anastomosis Versus Colon J Pouch for Reconstruction After Low Anterior Resection for Rectal Cancer (SAVE)
Primary hypothesis: Side-to-end anastomosis is non-inferior to colon J pouch for
reconstruction after low anterior resection for rectal cancer in fecal incontinence (Wexner
score).
Research questions: Are there differences between side-to-end anastomosis and colon J pouch
in
- bowel function (fecal incontinence, frequency of bowel movements, rectal urgency,
incomplete evacuation)
- quality of life
- sexual function
- urinary function
- postoperative complications
- operation time/ institutional costs
Experimental intervention: Low anterior resection for rectal cancer < 12 cm from the anal
verge with total mesorectal excision (TME), ligation of the inferior mesenteric artery close
to the aorta, mobilization of the splenic flexure, radical lymph node dissection and
side-to-end colorectal/ coloanal anastomosis (STE). The blind end of the descending colon
(3-5 cm long) is closed with a linear stapler. Stapling of the anastomosis is done by
introducing the stapler from the anus by the assistant surgeon while the surgeon is holding
the descending colon in the correct position. The anastomosis is performed on the
antimesenteric aspect of the descending colon. The length of the blind end is measured and
the integrity of the anastomosis is tested intraoperatively. The intended minimal distal
clearance margin from the tumor is 2 cm. A protective loop ileostomy will be performed
regularly which is intended to be closed 3 months postoperatively.
Control intervention: Low anterior resection for rectal cancer with total mesorectal
excision (TME), ligation of the inferior mesenteric artery close to the aorta, mobilization
of the splenic flexure, radical lymph node dissection and colon J pouch rectal/colon J pouch
anal anastomosis (CJP). The colon J Pouch is formed by the descending colon by stapling with
a defined pouch limb length of 5-6 cm, which is measured intraoperatively. The stapling is
done by introducing the stapler from the anus by the assistant surgeon while the surgeon is
holding the descending colon in the correct position. The integrity of the anastomosis is
tested intraoperatively. The intended minimal distal clearance margin from the tumor is 2
cm. A protective loop ileostomy will be performed regularly which is intended to be closed 3
months postoperatively.
Follow-up per patient: 24 months postoperatively
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06380101 -
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
|
N/A | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Recruiting |
NCT04323722 -
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
Active, not recruiting |
NCT01347697 -
Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer
|
N/A | |
Recruiting |
NCT04495088 -
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
|
Phase 3 | |
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03520088 -
PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS
|
N/A | |
Recruiting |
NCT05556473 -
F-Tryptophan PET/CT in Human Cancers
|
Phase 1 | |
Recruiting |
NCT04749381 -
The Role of TCM on ERAS of Rectal Cancer Patients
|
Phase 2 | |
Enrolling by invitation |
NCT05028192 -
Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
|
||
Recruiting |
NCT03283540 -
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
|
||
Completed |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
Recruiting |
NCT05914766 -
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
|
N/A | |
Recruiting |
NCT04852653 -
A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
|
||
Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A | |
Terminated |
NCT02933944 -
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
|
Phase 1 |